Hermann, Robert http://orcid.org/0000-0002-1326-5943
Krajcsi, Peter
Fluck, Markus
Seithel-Keuth, Annick
Bytyqi, Afrim
Galazka, Andrew
Munafo, Alain
Funding for this research was provided by:
merck healthcare kgaa (CrossRef Funder ID: 10.13039/100009945)
Article History
Accepted: 28 July 2021
First Online: 26 August 2021
Declarations
:
: The in vitro studies summarized in this report were sponsored by Merck Healthcare KGaA (CrossRef Funder ID: 10.13039/100009945).
: Robert Hermann served as an external clinical pharmacology expert advisor for various aspects in the clinical development of cladribine, and received financial support for research, consulting, and training services from Merck Healthcare KGaA, Darmstadt, Germany. Peter Krajcsi served as an external pharmacology expert advisor for in vitro transporter studies. He is a co-founder of Habilitas Kft, which received financial support for generation of an Internal Transporter Report from Merck Healthcare KGaA, Darmstadt, Germany. He was also an employee of Solvo Biotechnology, Budapest, Hungary, outside this advisory work. Annick Seithel-Keuth, Markus Fluck, and Afrim Bytyqi are employees of Merck Healthcare KGaA, Darmstadt, Germany. Andrew Galazka was an employee of Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA at the time of the study, and is currently a consultant to Merck Healthcare KGaA, Darmstadt, Germany. Alain Munafo is an employee of the Merck Institute of Pharmacometrics, Lausanne, Switzerland, an affiliate of Merck KGaA.
: Not applicable.
: Not applicable.
: Not applicable.
: Any requests for data by qualified scientific and medical researchers for legitimate research purposes will be subject to Merck Healthcare KGaA’s data sharing policy. All requests should be submitted in writing to Merck Healthcare KGaA’s data sharing portal: ExternalRef removed. When Merck Healthcare KGaA has a co-research, co-development, co-marketing, or co-promotion agreement, or when the product has been out-licensed, the responsibility for disclosure might be dependent on the agreement between parties. Under these circumstances, Merck KGaA will endeavor to gain agreement to share data in response to requests.
: Not applicable.
: All authors contributed to the concept, design, and critical review of the manuscript, and approved the final version for submission.